James Mahon
Overview
Explore the profile of James Mahon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCarroll K, Mahon J, Lannon R, Carroll A, Fitzpatrick D
Osteoporos Int
. 2025 Mar;
PMID: 40042619
No abstract available.
2.
Estimation of the health economic benefit of widening pulmonary rehabilitation uptake and completion
Steiner M, Mahon J, Fuld J, Hex N
Chron Respir Dis
. 2024 Dec;
21:14799731241307248.
PMID: 39648047
Increasing uptake and completion of Pulmonary Rehabilitation in people with COPD has the potential to deliver health benefit and reduce health inequalities. We have quantified the cost-effectiveness of enhancing PR...
3.
Fleeman N, Houten R, Nevitt S, Mahon J, Beale S, Boland A, et al.
Health Technol Assess
. 2024 Sep;
28(49):1-190.
PMID: 39252678
Background: Renal cell carcinoma is the most common type of kidney cancer, comprising approximately 85% of all renal malignancies. Patients with advanced renal cell carcinoma are the focus of this...
4.
Ghassan W, Basem A, Hawra A, Ahmad A, Muaddi A, Mestouri A, et al.
IJID Reg
. 2024 May;
11:100371.
PMID: 38808154
Objectives: The emergence of resistance to antiretroviral therapy (ART) has an impact on the cost of HIV care. This study aimed to estimate the direct and indirect costs associated with...
5.
Chaplin M, Bresnahan R, Fleeman N, Mahon J, Houten R, Beale S, et al.
Pharmacoecon Open
. 2023 Dec;
7(6):1015.
PMID: 38051493
No abstract available.
6.
Bresnahan R, Duarte R, Mahon J, Beale S, Chaplin M, Bhattacharyya D, et al.
Health Technol Assess
. 2023 Oct;
27(10):1-115.
PMID: 37839810
Background: Magnetic resonance imaging-based technologies are non-invasive diagnostic tests that can be used to assess non-alcoholic fatty liver disease. Objectives: The study objectives were to assess the diagnostic test accuracy,...
7.
Chaplin M, Bresnahan R, Fleeman N, Mahon J, Houten R, Beale S, et al.
Pharmacoecon Open
. 2023 Sep;
7(6):863-875.
PMID: 37731145
As part of the National Institute for Health and Care Excellence (NICE) highly specialised technology (HST) evaluation programme, Novartis submitted evidence to support the use of onasemnogene abeparvovec as a...
8.
Offiah C, Tierney S, Egan B, Collins R, Ryan D, McCarthy A, et al.
Ir J Med Sci
. 2023 Jun;
193(1):541.
PMID: 37269449
No abstract available.
9.
Bresnahan R, Houten R, Greenhalgh J, Nevitt S, Mahon J, Beale S, et al.
Pharmacoecon Open
. 2023 May;
7(4):525-536.
PMID: 37195551
As part of the Single Technology Appraisal (STA) process, the UK National Institute for Health and Care Excellence (NICE) invited Apellis Pharmaceuticals/Sobi to submit evidence for the clinical and cost...
10.
Houten R, Fleeman N, Mahon J, Chaplin M, Edwards K, Beale S, et al.
Pharmacoecon Open
. 2023 Apr;
7(3):345-358.
PMID: 37084172
The National Institute for Health and Care Excellence (NICE) provides guidance to improve health and social care in England and Wales. NICE invited Daiichi Sankyo to submit evidence for the...